(Q27851648)

13 November 2016

title

Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer (English)

1 reference

PubMed

13 November 2016

Both BRAF V600E Mutation and Older Age (≥65 Years) are Associated with Recurrent Papillary Thyroid Cancer (English)

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

2 December 2024

main subject

papillary thyroid cancer

1 reference

10

Yuri E Nikiforov

0 references

Sally E. Carty

2

Sally E Carty

0 references

Linwah Yip

11

Linwah Yip

0 references

Marina N Nikiforova

9

Marina N Nikiforova

0 references

Gina M Howell

1

Gina M Howell

0 references

Michaele J Armstrong

3

Michaele J Armstrong

0 references

Shane O Lebeau

4

Shane O Lebeau

0 references

Steven P Hodak

5

Steven P Hodak

0 references

Michael Stang

7

Michael T Stang

0 references

Kelly McCoy

8

Kelly L McCoy

0 references

author name string

Christopher Coyne

6

0 references

Michael T. Stang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21594703

2 December 2024

Kelly L. McCoy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21594703

2 December 2024

Yuri E. Nikiforov

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21594703

2 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21594703

2 December 2024

publication date

December 2011

0 references

19 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21594703

full work available at URL

2 December 2024

http://link.springer.com/content/pdf/10.1245/s10434-011-1781-5.pdf

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

http://link.springer.com/article/10.1245/s10434-011-1781-5/fulltext.html

2 December 2024

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

http://link.springer.com/content/pdf/10.1245/s10434-011-1781-5

2 December 2024

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

Annals of Surgical Oncology

2 December 2024

published in

0 references

volume

18

0 references

issue

13

0 references

page(s)

3566-71

0 references

cites work

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Specific features of differentiated thyroid carcinoma in patients over 70 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1781-5

Increasing incidence of thyroid cancer in the United States, 1973-2002

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

2 December 2024

3

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

Long-term results in elderly patients with differentiated thyroid carcinoma

2 December 2024

4

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis

2 December 2024

11

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

2 December 2024

17

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

2 December 2024

21

1 reference

https://api.crossref.org/works/10.1245/S10434-011-1781-5